Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study evaluates the effect in chronic migraine patients of daily 20 minute-transcutaneous sub occipital neurostimulation using the occipital Cefaly° device.
Chronic migraine is a disabling neurological condition affecting 0.5-2% of the population.
CM is difficult to treat and preventive treatment options are limited. Due to the inefficiency of available and the lack of new preventive anti-migraine drug, neurostimulation methods have raised great interest in recent years.
The ONSTIM study showed a reduction in headache frequency in 39% of patients treated with active ONS during 12 weeks, compared to no improvement in the "non-effectively" stimulated or medically treated groups.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Cefaly Kit Arnold | Experimental | Occipital transcranial stimulation is implemented in occipital region at 16 mA of intensity, for 20 minutes, everyday for 3 months, in 20 chronic migraine patients. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cefaly Kit Arnold | Device | Occipital neurostimulation can have a therapeutic effect in chronic migraine treatment, thus representing a possible therapeutic option in patients that do not respond to any medication. |
| Measure | Description | Time Frame |
|---|---|---|
| Monthly frequency of migraine days | 2 months treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Monthly frequency of headache days | 2 months | |
| Monthly frequency of total headache days | 2 months | |
| Cumulative monthly headache hours |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Anna Cosseddu, MD | Contact | +3242256925 | cossedduanna@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Jean Schoenen, MD, PhD | University of Liege | Principal Investigator |
| Delphine Magis, MD, PhD | University of Liege | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHR Citadelle | Recruiting | Liège | Belgium | 4000 | Belgium |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 2 months |
| Monthly acute drug intake | 2 months |